Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development (Q50127370)
Jump to navigation
Jump to search
scientific article published on September 1, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development |
scientific article published on September 1, 2010 |
Statements
1 reference
Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development (English)
1 reference
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development (English)
Christopher Banfield
1 reference
Rajesh Krishna
1 reference
Sandy Allerheiligen
1 reference
Jeffrey D. Wetherington
Julie A. Stone
1 September 2010
1 reference
1 reference
50
1 reference
9 Suppl
1 reference
31S-46S
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference